Literature DB >> 27467824

Prevalence of Primary HPV in Djibouti: Feasibility of Screening for Early Diagnosis of Squamous Intraepithelial Lesions.

Alessio Petrelli1, Anteo Di Napoli, Paolo Giorgi Rossi, Alessandra Rossi, Daniele Luccini, Ilaria Di Marco, Amadou Laico Traoré, Anna Gillio Tos, Morena Trevisan, Concetta Mirisola, Gianfranco Costanzo.   

Abstract

OBJECTIVE: In many African Sub-Saharan countries, human papilloma virus (HPV) prevalence data are not available. The current study estimated the prevalence of HPV virus in the female population of Djibouti.
METHODS: Approximately 1000 asymptomatic women 16 to 64 years old were enrolled from 3 of the main health structures of Djibouti in 2014 and 2015; 998 cervical samples were tested for HPV-DNA of high risk types, 499 during the first year, and 499 during the second. Positive samples were typed with an HPV genotyping kit.
RESULTS: The women were an average age of 38.8 years (SD, 10.2); 54 women tested positive for HPV (prevalence rate, 5.4% [95% confidence interval, 4.0-6.8]). The highest prevalence was observed among the women younger than 35 years. HPV66 was the most prevalent (15.4% of the infections), followed by HPV31 and HPV52 (10.8% both) and HPV16 (9.2%). All 54 women who tested HPV-positive underwent a Pap test, which was positive in 8 cases (14.8%): 2 high-grade squamous intraepithelial lesion (HSIL) and 6 low-grade (LSIL).
CONCLUSIONS: The HPV prevalence shows a curve by age similar to that of other African countries. The proportion of HPV16 is among the lowest ever seen in similar studies. The findings suggest to Djibouti the choice of a strategy of screening that includes forms of cytological triage, thus limiting recourse to colposcopy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27467824     DOI: 10.1097/LGT.0000000000000240

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  2 in total

1.  High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.

Authors:  Ralph-Sydney Mboumba Bouassa; Zita Aleyo Nodjikouambaye; Damtheou Sadjoli; Chatté Adawaye; Hélène Péré; David Veyer; Mathieu Matta; Leman Robin; Serge Tonen-Wolyec; Ali Mahamat Moussa; Donato Koyalta; Laurent Belec
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240

2.  Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach.

Authors:  Deeksha Salaria; Rajan Rolta; Jyoti Mehta; Oladoja Awofisayo; Olatomide A Fadare; Baljinder Kaur; Balvir Kumar; Renato Araujo da Costa; Shikha Rangra Chandel; Neha Kaushik; Eun Ha Choi; Nagendra Kumar Kaushik
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.